HCPLive Network

ADHD

Taking medication for attention-deficit/hyperactivity disorder might reduce the risk of young patients accidentally injuring themselves, new research suggests. The findings, published online Dec. 15 in Pediatrics, applied to both girls and boys.
Two generic versions of the attention-deficit/hyperactivity disorder drug Concerta may not work as effectively as the brand-name product does, the US Food and Drug Administration said Thursday.
The brains of children and adolescents with attention deficit hyperactivity disorder (ADHD) are slower to develop some key connections, according to a study published in the Proceedings of the National Academy of Sciences.
Otezla (apremilast) is an oral, selective phosphodiesterase 4 (PDE4) inhibitor for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Adding an antipsychotic medication, such as risperidone, to stimulant therapy and parent training may improve parent ratings for behavioral problems in children with attention-deficit/hyperactivity disorder, according to research published in the September issue of the Journal of the American Academy of Child & Adolescent Psychiatry.
Attention-deficit/hyperactivity disorder stimulant treatment in children is not associated with significant changes in growth, according to a study published online Sept. 1 in Pediatrics.
ADHD Upcoming Events
ADHD Latest News
ADHD Clinical Trials
ADHD Resources